StockData
InspireMD, Inc. logo

InspireMD, Inc. (NSPR) company profile

NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3054% below fair value
$0.65+0.05 (+8.33%)

Close on Nov 17, 2026Market cap $30.22MP/E –Yield –

About InspireMD

Surgical & Medical Instruments & Apparatus, SIC 3841

InspireMD is a medical device company that develops and commercializes products for treating carotid artery disease and other vascular conditions. Its core proprietary offering centers on the MicroNet mesh sleeve paired with self-expanding nitinol stents to prevent embolic debris from causing strokes during and after carotid interventions. The company’s commercial portfolio includes the CGuard Carotid Embolic Prevention System, which holds European MDR CE Mark approval, and the CGuard Prime Carotid Stent System, which holds both U.S. FDA premarket approval and MDR CE Mark certification. In addition, the business is developing neuroprotection systems and expanding into transcarotid revascularization and acute stroke therapies. Its customers comprise physicians, healthcare facilities, and patients requiring carotid revascularization.

The company markets its products internationally across more than 30 countries outside the United States through independent distributors, alongside direct sales operations in the United States. Its global headquarters is located in Miami, Florida.

Summary of the business section of InspireMD's latest annual report, written by StockData.

Company profile

Company

Legal name
InspireMD, Inc.
Founded
2008
Headquarters
Miami, FL
Address
6303 Waterford District Drive, Suite 215 33126
Phone
(888) 776-6804
Employees
127, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Kesselman & Kesselman, Tel-Aviv, Israel

Stock & identifiers

Ticker
NSPR
Exchange
Nasdaq
IPO date
Apr 12, 2011
Shares outstanding
46M, Aug 14, 2026
Public float
$60.93M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-15 reverse, Apr 27, 2021; 1-for-50 reverse, Apr 1, 2019; 1-for-35 reverse, Feb 13, 2018; 1-for-25 reverse, Oct 10, 2016; 1-for-10 reverse, Oct 1, 2015; 1-for-4 reverse, Dec 21, 2012
SEC CIK
1433607
CUSIP
45779A846
ISIN
US45779A8466
FIGI
BBG000QDM9D4
Share class FIGI
BBG001T6WG65
LEI
549300OQ16IJ5DIS5D30
EIN
26-2123838

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Marvin SlosmanCEO and President, Director3,602,812
Michael A. LawlessChief Financial Officer807,080
Shane Thomas GleasonChief Commercial Officer1,053,882
Andrea TommasoliChief Operating Officer954,389
Craig ShoreCFO and CAO1,112,460
Patrick VertaEVP Clinical/Medical Affairs311,532
Gary S. RoubinDirector988,324
Michael BermanDirector674,503
Paul StukaDirector1,399,268
Scott R. WardDirector237,096
Raymond W. CohenDirector92,417
Danny L. DearenDirector102,047
Kathryn ArnoldDirector303,087
Thomas J. KesterDirector458,573

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$3.10M$1.32M$1.83M$207–
FY2024$3.30M$2.36M$1.58M$306–
FY2023$3.22M$5.87M$1.45M$327–
FY2022$696.81K$115.27K$492.25K$17–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOption awardsIncentive payOtherTotalvs. prior year
Marvin Slosman
President and Chief Executive Officer
$588.50K$397.24K$1.54M$544.45K–$23.77K$3.10M-6%
Craig Shore
Former Chief Financial Officer, Chief Administrative Officer, Secretary and Treasurer *
$261.10K$132.81K$642.02K$226.80K–$1.09M$2.35M+44%
Michael Lawless
Chief Financial Officer, Secretary and Treasurer
$187.50K$87.38K$1.04M$353.36K–$17.45K$1.69M–
Shane Gleason
Chief Commercial Officer
$367.50K$82.69K$642.02K$226.80K$107.14K$22.14K$1.45M-5%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“of December 31, 2025, we had 127 full-time employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jul 23, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 15, 2022DelistingNotice of delisting from exchange (Form 25)
Jun 7, 2021DelistingNotice of delisting from exchange (Form 25)
May 27, 2021Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 20, 2021ListingRegistration of securities on an exchange (Form 8-A)
May 20, 2021DelistingNotice of delisting from exchange (Form 25)
May 10, 2021Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 9, 2019Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 11, 2019Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 19, 2018Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 8, 2017Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 29, 2017Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 22, 2017Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 4, 2017ListingRegistration of securities on an exchange (Form 8-A)
Jul 26, 2016ListingRegistration of securities on an exchange (Form 8-A)
Jan 21, 2015Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Oct 25, 2013ListingRegistration of securities on an exchange (Form 8-A)
Mar 12, 2013ListingRegistration of securities on an exchange (Form 8-A)
Nov 8, 2012ListingRegistration of securities on an exchange (Form 8-A)
Apr 14, 2011Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 6, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 6, 2011Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 1, 2011Name changeName changed from Saguaro Resources, Inc. to InspireMD, Inc.

See a number that looks wrong?